Literature DB >> 3805316

Comparison of erythrocyte antioxidative enzyme activities between two types of haemoglobin H disease.

S Prasartkaew, A Bunyaratvej, S Fucharoen, P Wasi.   

Abstract

The activities of erythrocyte antioxidative enzymes were measured in two groups of patients with different genotypes of haemoglobin (Hb) H disease: 21 with alpha-thalassaemia 1 or alpha-thalassaemia 2 (alpha-thalassaemia 1/2) and 21 with alpha-thalassaemia 1/Hb Constant Spring (HbCS). They were compared with 21 normal subjects. Both genotypes of Hb H disease had increased activities of erythrocyte superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase when compared with those of controls. Comparison of the two genotypes showed that subjects with alpha-thalassaemia 1/Hb CS, the more severe disease, had higher SOD and GSH-Px activities but lower catalase activity than those with alpha-thalassaemia 1/2. This indicates that there are compensatory mechanisms in Hb H erythrocytes to cope with increased generation of oxygen free radicals as a result of increased excess beta chain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3805316      PMCID: PMC1140791          DOI: 10.1136/jcp.39.12.1299

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

Review 1.  Superoxide dismutases.

Authors:  I Fridovich
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Identification of the abnormal polypeptide chain of hemoglobin G-Ib.

Authors:  D B GAMMACK; E R HUEHNS; E M SHOOTER; P S GERALD
Journal:  J Mol Biol       Date:  1960-12       Impact factor: 5.469

3.  A low Km phosphoenolpyruvate mutant in the Amish with red cell pyruvate kinase deficiency.

Authors:  F A Oski; H Bowman
Journal:  Br J Haematol       Date:  1969-09       Impact factor: 6.998

4.  Rapid electrophoresis and quantitation of haemoglobins on cellulose acetate.

Authors:  A J Marengo-Rowe
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

5.  Alpha- and beta-thalassemia in Thailand.

Authors:  P Wasi; S Na-Nakorn; S Pootrakul; M Sookanek; P Disthasongchan; V Panich; M Pornpatkul
Journal:  Ann N Y Acad Sci       Date:  1969-11-20       Impact factor: 5.691

6.  International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis.

Authors:  E Beutler; K G Blume; J C Kaplan; G W Löhr; B Ramot; W N Valentine
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998

7.  Levels of haemoglobin H and proportions of red cells with inclusion bodies in the two types of haemoglobin H disease.

Authors:  P Adirojnanon; P Wasi
Journal:  Br J Haematol       Date:  1980-11       Impact factor: 6.998

8.  The estimation of red cell superoxide dismutase activity.

Authors:  C C Winterbourn; R E Hawkins; M Brian; R W Carrell
Journal:  J Lab Clin Med       Date:  1975-02

9.  In vivo and in vitro variations of human erythrocyte glutathione peroxidase activity as result of cells ageing, selenium availability and peroxide activation.

Authors:  G Perona; G C Guidi; A Piga; R Cellerino; R Menna; M Zatti
Journal:  Br J Haematol       Date:  1978-07       Impact factor: 6.998

10.  Increased erythrocyte superoxide dismutase activities in beta 0-thalassaemia/haemoglobin E and in haemoglobin H diseases.

Authors:  P Yenchitsomanus; P Wasi
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

View more
  4 in total

1.  Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes.

Authors:  Y Yuthavong; P Butthep; A Bunyaratvej; S Fucharoen
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Effect of Yisui Shengxue Granule () on the oxidative damage of erythrocytes from patients with hemoglobin H disease.

Authors:  Wen-Juan Wang; Zhi-Kui Wu; Xin-Hua Zhang; Yong-Mei Liu; Su-Ping Fang; Chong Zhang; Wen-Jun Liu; Min Li; Rong-Xin Wang; Rui-Gui Luo; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2012-08-31       Impact factor: 1.978

3.  Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.

Authors:  Sri Riyati Sugiarto; Brioni R Moore; Julie Makani; Timothy M E Davis
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

4.  Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?

Authors:  Eric A Gbessi; Offianan A Toure; Albert Gnondjui; Tossea S Koui; Baba Coulibaly; Berenger A Ako; Nguessan L Tiacoh; Serge-Brice Assi; Ibrahima Sanogo; Didier-Paulin Sokouri; Ronan Jambou
Journal:  Parasite       Date:  2021-09-27       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.